Combining miRNA and mRNA Expression Profiles in Wilms Tumor Subtypes

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Wilms tumor (WT) is the most common pediatric kidney cancer.
• Mutations in microRNA (miRNA) processing proteins highlight miRNAs' role in WT.
• Understanding miRNA expression is crucial for WT subtyping and targeted therapies.

Purpose of the Study:

• To investigate miRNA expression profiles in different Wilms tumor subtypes.
• To identify correlations between miRNA and messenger RNA (mRNA) expression in WT.
• To explore the role of miRNAs in WT pathogenesis and potential therapeutic strategies.

Main Methods:

• miRNA expression profiling using microarrays on 36 WT samples and 4 normal kidney tissues.
• Gene expression profiling of 28 WT samples.
• Hierarchical clustering for sample separation and correlation analysis between miRNA and mRNA.

Main Results:

• Distinct miRNA and mRNA expression profiles were identified for blastemal and regressive WT subtypes.
• miRNA profiling provided better separation of WT subtypes compared to mRNA profiling.
• Significant upregulation of specific miRNAs (e.g., miR-183, miR-301a/b, miR-335 in blastemal WT; miR-181b, miR-223, miR-630 in regressive WT) was observed.
• Deregulation of miRNAs involved in epithelial-mesenchymal transition and chemosensitivity was noted.

Conclusions:

• miRNA expression patterns are significantly altered in Wilms tumor and can distinguish between subtypes.
• Specific miRNAs are associated with distinct WT subtypes, suggesting their involvement in tumor progression.
• Further research into miRNA roles in WT may lead to novel diagnostic and therapeutic approaches for childhood kidney cancer.